Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) today announced the commercialization of the MicrocynAH® family of animal healthcare products in Japan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE